Trials / Completed
CompletedNCT00543868
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 462 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will determine how if MK0782 is safe and tolerable and to determine how often and the severity of stomach and small intestine ulcers develop following administration of MK0782 plus enteric coated aspirin, rofecoxib 25mg plus enteric coated aspirin, naproxen 500 mg puls enteric coated asprin vs placebo. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0782 |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2004-08-01
- Completion
- 2004-08-01
- First posted
- 2007-10-15
- Last updated
- 2015-06-11
Source: ClinicalTrials.gov record NCT00543868. Inclusion in this directory is not an endorsement.